Establishment Labs Holdings, Inc. (ESTA)
62.78
-1.07
(-1.68%)
USD |
NASDAQ |
Oct 08, 10:25
Establishment Labs Holdings Enterprise Value : 2.095B for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 2.095B |
| October 06, 2026 | 2.138B |
| October 05, 2026 | 2.173B |
| October 02, 2026 | 2.101B |
| October 01, 2026 | 2.071B |
| September 30, 2026 | 2.104B |
| September 29, 2026 | 2.090B |
| September 28, 2026 | 2.139B |
| September 25, 2026 | 2.158B |
| September 24, 2026 | 2.146B |
| September 23, 2026 | 2.211B |
| September 22, 2026 | 2.285B |
| September 21, 2026 | 2.211B |
| September 18, 2026 | 2.257B |
| September 17, 2026 | 2.265B |
| September 16, 2026 | 2.313B |
| September 15, 2026 | 2.322B |
| September 14, 2026 | 2.335B |
| September 11, 2026 | 2.306B |
| September 10, 2026 | 2.319B |
| September 09, 2026 | 2.412B |
| September 08, 2026 | 2.436B |
| September 04, 2026 | 2.406B |
| September 03, 2026 | 2.347B |
| September 02, 2026 | 2.425B |
| Date | Value |
|---|---|
| September 01, 2026 | 2.265B |
| August 31, 2026 | 2.258B |
| August 28, 2026 | 2.297B |
| August 27, 2026 | 2.332B |
| August 26, 2026 | 2.351B |
| August 25, 2026 | 2.342B |
| August 24, 2026 | 2.339B |
| August 21, 2026 | 2.358B |
| August 20, 2026 | 2.323B |
| August 19, 2026 | 2.438B |
| August 18, 2026 | 2.433B |
| August 17, 2026 | 2.475B |
| August 14, 2026 | 2.560B |
| August 13, 2026 | 2.445B |
| August 12, 2026 | 2.444B |
| August 11, 2026 | 2.406B |
| August 10, 2026 | 2.429B |
| August 07, 2026 | 2.499B |
| August 06, 2026 | 2.548B |
| August 05, 2026 | 2.911B |
| August 04, 2026 | 3.011B |
| August 03, 2026 | 2.957B |
| July 31, 2026 | 2.950B |
| July 30, 2026 | 2.978B |
| July 29, 2026 | 2.931B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 198.50B |
| AngioDynamics, Inc. | 548.82M |
| Alphatec Holdings, Inc. | 2.074B |
| AtriCure, Inc. | 2.618B |
| Baxter International, Inc. | 19.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.75M |
| Revenue (Quarterly) | 67.54M |
| Total Expenses (Quarterly) | 79.29M |
| EPS Diluted (Quarterly) | -0.39 |
| Gross Profit Margin (Quarterly) | 70.64% |
| Profit Margin (Quarterly) | -17.39% |
| Earnings Yield | -2.07% |
| Normalized Earnings Yield | -2.072 |